Wanbury, a company in the Pharmaceuticals industry, reported revenue of ₹183 crore and net profit of ₹12 crore for the September 2026 quarter.
Wanbury (NSE: WANBURY) closed at ₹179.37 on 20 Nov 2026, down 22.1% over the past year. Its market capitalisation is ₹627 crore and it trades at 11.2 times earnings.
Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.